IHS Markit and OpenGamma join forces to help clients with UMR
27 May 2020 London
Image: frank60/Shutterstock.com
IHS Markit and OpenGamma, a margin optimisation provider, have collaborated in a bid to help mutual clients reduce the cost of margin management under the Uncleared Margin Rules (UMR).
The offering will unite OpenGamma’s pre-trade margin analytics with IHS Markit’s post-trade derivatives calculation service and aims to provide end-to-end support for in-scope entities.
According to IHS Markit, when combined with OpenGamma’s strength in margin analytics for cleared and bilateral derivatives, mutual clients can fully manage pre- and post-trade requirements through a single solution with flexible delivery options.
The collaboration comes after global regulators introduced a one-year delay to phases five and six of margin requirements for UMR.
The final two phases of UMR, scheduled for September 2021 and September 2022 respectively, will bring into scope numerous institutional asset managers, creating an increased demand for tools that help reduce the cost of posting margin.
Hiroshi Tanase, executive director at IHS Markit, says: “Together with OpenGamma, we are excited to help firms achieve regulatory compliance and a competitive edge through margin validation and optimisation.
“Our forward-looking solution, powered by highly-accurate margin analytics and calculations, can effectively streamline margin workflows and over the counter derivatives trading to enable cost mitigation.”
Peter Rippon, CEO of OpenGamma, adds: “Asset managers are currently working out how to best use the time afforded to them by the UMR delay. Many firms are underestimating the complexity involved in pricing bilateral derivatives.
"IHS Markit is one of the very few firms that has the proven pedigree in this area. Together, our combined solution offers full coverage for both cleared and bilateral derivatives.”
The offering will unite OpenGamma’s pre-trade margin analytics with IHS Markit’s post-trade derivatives calculation service and aims to provide end-to-end support for in-scope entities.
According to IHS Markit, when combined with OpenGamma’s strength in margin analytics for cleared and bilateral derivatives, mutual clients can fully manage pre- and post-trade requirements through a single solution with flexible delivery options.
The collaboration comes after global regulators introduced a one-year delay to phases five and six of margin requirements for UMR.
The final two phases of UMR, scheduled for September 2021 and September 2022 respectively, will bring into scope numerous institutional asset managers, creating an increased demand for tools that help reduce the cost of posting margin.
Hiroshi Tanase, executive director at IHS Markit, says: “Together with OpenGamma, we are excited to help firms achieve regulatory compliance and a competitive edge through margin validation and optimisation.
“Our forward-looking solution, powered by highly-accurate margin analytics and calculations, can effectively streamline margin workflows and over the counter derivatives trading to enable cost mitigation.”
Peter Rippon, CEO of OpenGamma, adds: “Asset managers are currently working out how to best use the time afforded to them by the UMR delay. Many firms are underestimating the complexity involved in pricing bilateral derivatives.
"IHS Markit is one of the very few firms that has the proven pedigree in this area. Together, our combined solution offers full coverage for both cleared and bilateral derivatives.”
NO FEE, NO RISK
100% ON RETURNS If you invest in only one securities finance news source this year, make sure it is your free subscription to Securities Finance Times
100% ON RETURNS If you invest in only one securities finance news source this year, make sure it is your free subscription to Securities Finance Times
